The dog-days of summer produced just a handful of mergers and acquisitions in the medtech sector and no blockbuster deals. However, several companies made smaller deals for innovative products in a range of sectors including IVDs, cardiovascular devices, and ophthalmology.
There were only 13 medtech deals in August, according to Medtech Insight's Mergers & Acqusitions Tracker, and there were no deals worth more than $500m. But the few deals that did go through represent a broad spectrum of industry subsectors and innovative technologies.
The list of medtech deals for August includes eight for which the terms were not disclosed by the companies, four...
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.
CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.
